Atlas Trials

To Evaluate Patient Preference of Movantik and Polyethylene Glycol 3350 for Opioid Induced Constipation

Clinical trial NCT03060512 · COMPLETED

Trial details

NCT number
NCT03060512
Sponsor
AstraZeneca
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Opioid Induced Constipation
Start date
2017-03-02
Primary completion
2017-08-23
Enrollment
276

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.